Arotech's Armour of America Receives Over $1 Million Order from U.S. Department of Defense (DoD) for Armor Products

May 14, 2008 - Arotech Corporation (NasdaqGM: ARTX) announced today that its Armor Division’s Armour of America unit has received over $1 million in orders from DoD for armor solutions.

The order consists of various types of personnel armor solutions from AoA’s state-of-the-art line of ballistics products and fragmentation kits, including ArmorFloat TM (a ballistic floatation device) and Leguard TM (a ballistic knee and leg protection device).

“We are pleased with Armour of America’s continued turnaround and their acceptance by defense contractors as a critical source of protection for military personnel and military equipment world wide,” stated Robert S. Ehrlich, Chairman and CEO of Arotech Corporation. “We continue to gain recognition throughout the industry as a “one stop shop” for personnel armor solutions,” concluded Ehrlich.

About Arotech's Armor Division:

Arotech’s Armor Division is an innovative leader in lightweight armoring for vehicles. The Armor Division has years of battlefield and commercial protection experience and has provided life saving protection under the most extreme conditions. In addition to armoring vehicles for military and commercial customers, Arotech manufactures armor kits for military vehicles, aviation armor both for helicopters and for fixed wing aircraft, marine armor, personnel armor and fragmentation blankets.

The Armor Division consists of MDT Protective Industries Ltd., MDT Armor Corporation and Armour of America Incorporated.

About Arotech Corporation

Arotech Corporation is a leading provider of quality defense and security products for the military, law enforcement and homeland security markets, including multimedia interactive simulators/trainers, lightweight armoring and advanced zinc-air and lithium batteries and chargers. Arotech operates through three major business divisions: Armor, Training & Simulation, and Battery & Power Systems.

Arotech is incorporated in Delaware, with corporate offices in Ann Arbor, Michigan, and research, development and production subsidiaries in Alabama, Michigan, and Israel. For more information on Arotech, please visit Arotech’s website at www.arotech.com.

Except for the historical information herein, the matters discussed in this news release include forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management’s current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, readers are cautioned not to place undue reliance on these forward-looking statements, as they are subject to various risks and uncertainties that may cause actual results to vary materially. These risks and uncertainties include, but are not limited to, risks relating to: product and technology development; the uncertainty of the market for Arotech’s products; changing economic conditions; delay, cancellation or non-renewal, in whole or in part, of contracts or of purchase orders; and other risk factors detailed in Arotech’s most recent Annual Report on Form 10-K for the fiscal year ended December 31, 2007, as amended, and other filings with the Securities and Exchange Commission. Arotech assumes no obligation to update the information in this release. Reference to the Company’s website above does not constitute incorporation of any of the information thereon into this press release.